Page 174 - Programme book for The International Liver Congress 2015, EASL ILC 2015

Liver Tumours: Experimental (Cont.)

YI P0315 INCREASED AEROBIC GLYCOLISIS IS ASSOCIATED WITH
POOR OUTCOME AND SUPPRESSION OF APOPTOSIS IN
HUMAN LIVER CIRRHOSIS AND HCC
Valeria Iansante, Pui Man Choy*, Shilpa Chokshi, Roger Williams,
Robert A. Anders, Concetta Bubici, Salvatore Papa, The United Kingdom

YI P0316 DESPITE REPRESSING IGF-1R, MIR-181A HALTS THE
TUMOR-SUPPRESSOR ACTIVITY OF DECORIN BY
EHNANCING TUMOR PROGRESSION IN HEPATOCELLULAR
CARCINOMA
Reem A. Assal*, Hend M. El Tayebi, Karim A. Hosny, Gamal Esmat,
Ahmed I. Abdelaziz, Egypt

YI P0317 DOWN-REGULATION OF HAO2 IS ASSOCIATED WITH
THE ONSET AND DEVELOPMENT OF HEPATOCELLULAR
CARCINOMA IN RODENTS
Sandra Mattu*, Andrea Perra, Silvia Menegon, Marta A. Kowalik,
Annalisa Petrelli, Giovanna M. Ledda-Columbano, Silvia Giordano,
Amedeo Columbano, Italy

ePOSTERS YI P0318 ULTRA-DEEP SEQUENCING OF MULTIPLEX-PCR
ENRICHED HOTSPOT AND DISEASE-RELATED TARGETS
IN HEPATOCELLULAR CARCINOMA
Wafa Amer*, Ulrike Koitzsch, Claudia Vollbrecht, Alexander Quaas,
Raed Samara, Anne Arens, Reinhard Büttner, Uta Drebber, Jia Huang,
Margarete Odenthal, Germany

YI P0319 IDENTIFICATION OF MOLECULAR ALTERATIONS
INDUCED BY TARGETING METABOLISM IN
HEPATOCELLULAR CARCINOMA
Zeribe C. F. Nwosu*, Joaquim Moreno-Càceres, Christoph Meyer,
Steven Dooley, Germany

YI P0320 TARGETING TGF-BETA I WITH THE TRANSFORMING
GROWTH FACTOR RECEPTOR TYPE I KINASE INHIBITOR,
LY2157299, MODULATES STEMNESS-RELATED
BIOMARKERS IN HEPATOCELLULAR CARCINOMA
Bhavna Rani*, Francesco Dituri,Yuan Cao, Ulla EngströmLuigi Lupo,
Steven Dooley, Aristidis Moustakas, Gianluigi Giannelli, Italy

174 The International Liver Congress™ 2015 • ILC Programme